- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05321472
Artificial Intelligence-assisted Common Bile Duct Stent Selection in Endoscopic Retrograde Cholangiopancreatography
Study Overview
Status
Detailed Description
Endoscopic Retrograde Cholangiopancreatography (ERCP) is an operation with high risk. Common bile duct stone and stenosis are important indications. The quality control of ERCP is the key to improve its success rate and reduce complications, which has received great attention. In 2015, the American Society of Gastrointestinal Endoscopy/American College of Gastroenterology (ASGE/ACG) issued ERCP quality control indicators, among which biliary stent placement and radiographic fluoroscopy time are important intraoperative quality control indicators.
The selection of appropriate biliary stent size is not only conducive to successful stent implantation but also to improve the prognosis of patients. Choose a stent of appropriate length. The proximal side of the stent should be 1cm above the obstruction segment, and the distal tail should be located just outside the nipple. The length of the stent can be determined by measuring the distance between the proximal end of the obstruction and the nipple under X-ray.
Current stent size selection is based on the operator's empirical estimation :(1) estimate the distance by endoscope diameter or cone length or catheter marking; (2) By retracting the guidewire, calculate the distance of the guidewire retracting between two points to estimate the length of the stent.The long radiation exposure time results in unnecessary injuries to both the operator and the patient.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Rui Ji, MD, PhD
- Phone Number: 18560086103
- Email: qljirui@email.sdu.edu.cn
Study Contact Backup
- Name: Yanqing Li, MD, PhD
- Phone Number: 053182169385
- Email: liyanqing@sdu.edu.cn
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Recruiting
- Department of Gastroenterology,QiLu Hospital,Shandong University
-
Contact:
- Rui Ji, MD, PhD
- Phone Number: 18560086103
- Email: qljirui@email.sdu.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients older than 18 years old who underwent ERCP
Exclusion Criteria:
- failed cholangiopancreatography caused by failed intubation, gastric retention, duodenal disease and so on
- patients proved no stenosis in common bile duct
- poor cholangiograms due to the lack of contrast agent or insufficient filling of contrast agent (cholangiograms without the completed CBD or thumbnails)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
group for training the algorithm
This group of images is used for training the algorithm of the artificial intelligence
|
group for testing the algorithm
This group of images is used for testing the algorithm of the artificial intelligence
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The accuracy of the calculated length of the stents by the artificial intelligence
Time Frame: 6 months
|
The length of the stent was calculated "the length from the stenosis to the papilla+2cm".The length of the stent selected by experts is the gold standard
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The accuracy of the segmentation of the artificial intelligence
Time Frame: 4 months
|
The accuracy of the segmentation of the common bile duct, duodenoscopy and stenosis lesions by the artificial intelligence
|
4 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Adler DG, Lieb JG 2nd, Cohen J, Pike IM, Park WG, Rizk MK, Sawhney MS, Scheiman JM, Shaheen NJ, Sherman S, Wani S. Quality indicators for ERCP. Gastrointest Endosc. 2015 Jan;81(1):54-66. doi: 10.1016/j.gie.2014.07.056. Epub 2014 Dec 2. No abstract available. Erratum In: Gastrointest Endosc. 2015 Apr;81(4):1060.
- Huang L, Lu X, Huang X, Zou X, Wu L, Zhou Z, Wu D, Tang D, Chen D, Wan X, Zhu Z, Deng T, Shen L, Liu J, Zhu Y, Gong D, Chen D, Zhong Y, Liu F, Yu H. Intelligent difficulty scoring and assistance system for endoscopic extraction of common bile duct stones based on deep learning: multicenter study. Endoscopy. 2021 May;53(5):491-498. doi: 10.1055/a-1244-5698. Epub 2020 Nov 9.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2021-SDU-QILU-090
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endoscopic Retrograde Cholangiopancreatography
-
Indiana UniversityCompletedCholangiopancreatography, Endoscopic RetrogradeUnited States
-
Boston Scientific CorporationCompletedEndoscopic Retrograde CholangiopancreatographyUnited States, Netherlands
-
Helsinki University Central HospitalCompletedEndoscopic Retrograde CholangiopancreatographyFinland
-
Ambu A/SAmbu Inc.; Infinite Clinical Solutions; Prelude DynamicsCompletedEndoscopic Retrograde Cholangiopancreatography (ERCP)United States
-
University of California, IrvineCompletedEndoscopic Retrograde Cholangiopancreatography (ERCP) | Endoscopic Ultrasound (EUS)United States
-
Kliniken Ludwigsburg-Bietigheim gGmbHNot yet recruitingCholangiopancreatography, Endoscopic Retrograde
-
Olympus Europe SE & Co. KGTerminatedCholangiopancreatography, Endoscopic RetrogradeBelgium, Germany, Norway
-
Boston Scientific CorporationCompletedEndoscopic Retrograde CholangiopancreatographyUnited States
-
Helsinki University Central HospitalTurku University Hospital; Oulu University HospitalCompletedEndoscopic Retrograde CholangiopancreatographyFinland
-
University Hospital, LinkoepingCompletedEndoscopic Retrograde CholangiopancreatographySweden